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Carotid Endarterectomy in Asymptomatic Patients With Limited Life
Expectancy
Wallaert JB, De Martino RR, Finlayson SRG, et al. Stroke 2012;43:1781-7
Conclusion: Carotid endarterectomy (CEA) is commonly performed
in asymptomatic patients with life-limiting conditions. The net benefit of
CEA in this population is uncertain.
Summary: Numerous guidelines are in place regarding which patients
with asymptomatic carotid stenosis should be considered for prophylactic
CEA. The Society for Vascular Surgery guidelines indicate that asymptom-
atic patients with 60% carotid artery stenosis can be considered for CEA
when life expectancy is 3 years and the perioperative stroke and death risk
is 3% (Ricotta JJ et al, J Vasc Surg 2011;54e1-e31). Other societies have
more strict indications and assert that appropriate candidates should have a
life expectancy 5 years (Goldstein LB et al, Stroke 2011;42:517-84; and
Chaturvedi S et al, Neurology 2005;65:794-801). The American Academy
ofNeurology (Chaturvedi S et al, reference) supports CEA for asymptomatic
disease only if patients are aged75 years. However, anecdotally, it appears
many patients undergo CEA outside of societal guidelines. The authors
sought to examine how commonly CEA was performed in asymptomatic
patients with limited life expectancy. They used the American College of
Surgeons National Quality Improvement Project data to identify eight
conditions associated with limited life expectancy based on survival estimates
using external sources: disseminated cancer, advanced liver disease, symp-
tomatic congestive heart failure, dialysis dependence, severe chronic ob-
structive pulmonary disease, age 90 years, American Society of Anesthesi-
ologist class 4, and do-not-resuscitate (DNR) status as indicators of limited
life expectancy. The predicted 5-year mortality in all but the DNR group
varies from 46% to 83%. Comparisons were then made of 30-day stroke rate,
death, and myocardial infarction after CEA between asymptomatic patients
with and without life-limiting conditions. There were 12,631 CEAs per-
formed in asymptomatic patients, of which 2,525 (20%) were performed in
patients with life-limiting conditions or diagnoses. The most common
conditions were severe chronic obstructive pulmonary disease and American
Society of Anesthesiologist class 4 designation. Patients with life-limiting
conditions had higher rates of perioperative complications, including stroke,
(1.8% vs 0.9%, P  .01), death (1.4% vs 0.3%, P  .01), and stroke/death
(2.9% vs 1.1%, P .001). After adjustment for other comorbidities, patients
with life-limiting conditions were still nearly three times more likely to
experience perioperative stroke or death than those without these conditions
(odds ratio, 2.1; 95% confidence interval, 2.1-3.8; P .001). The incidence
of myocardial infarction was 1%.
Comment: The data as presented in the original abstract are a bit
misleading. Of the nearly 13,000 patients undergoing prophylactic CEA,
the very large majority deemed to have life threatening conditions had severe
chronic obstructive pulmonary disease or American Society of Anesthesiol-
ogist class 4. Only 10 patients had advanced liver disease, 21 had advanced
cancer, 25 patients had a DNR status, 108 were aged 90 years, and 110
were dialysis-dependent. The decision to perform surgery is an individual
one between the physician and the patient. Data such as this are never privy
to individual circumstances surrounding operative decisions. For example,
clearly not all 90-year-old patients and not all dialysis-dependent patients are
the same. Conversely, as pointed out by the authors, the National Quality
Improvement Project database may underestimate perioperative myocardial
infarction and stroke. Nevertheless, although prophylactic CEA may be an
overused procedure, the stroke and death rates in the patients with so-called
limited life expectancy were actually less than those advocated by the American
Heart Association for patients with asymptomatic carotid stenosis. Without
actual survival data on the so-called patients with limited life expectancy, the
report can be considered a bit more inflammatory than informative.
Endovascular Suitability and Outcome After Open Surgery for Rup-
tured Abdominal Aortic Aneurysm
Dick F, Diehm N, Opfermann P, et al. Br J Surg 2012;99:940-47.
Conclusion: Endovascular suitability is an independent and strongly
positive predictor of survival after open repair of ruptured abdominal aortic
aneurysm (rAAA).
Summary: Analyses of open vs endovascular repair of rAAA suggest
improved procedure-related mortality rates with endovascular repair of
rAAA (Harkin DW et al, Eur J Vasc Endovasc Surg 2007;34:673-81; and
Smith J et al, Eur J Vasc Endovasc Surg 2002;23:336-43). However, a
randomized comparison of endovascular vs open repair for rAAA did not
demonstrate a survival advantage for endovascular repair (Hinchliffe RJ et al,
Eur J Vasc Endovasc Surg 2006;32:506-13). The present study sought to
test the hypothesis that endovascular suitability itself predicts survival after
surgery for rAAA. The authors used two blinded investigators to indepen-
dently evaluate preoperative CT angiograms of consecutive patients with
rAAA. When assessments of suitability agreed between the two observers,
patients were categorized as “suitable” or “unsuitable” for endovascular
repair. If assessments disagreed, patients were classified as “borderline suit-
able.” Correlations between endovascular suitability and clinical outcome
were adjusted for suspected compounding factors and tested for robustness
using sensitivity analysis. Between January 2001 and December 2010, 237
of 248 patients with rAAA (95.6%) underwent open repair. Seventy patients
(28.2%) were classified as suitable, 100 (40.3%) as unsuitable for endovas-
cular repair, and 63 (25.4%) were considered borderline suitable for endo-
vascular repair. Postoperative 30-day mortality was 15.3% (38 deaths).
Multiple logistic regression analysis demonstrated that the odds of preoper-
ative death increased 9.2-fold (95% confidence interval, 2.16-39.23) for
“unsuitable” rAAA (P .003) and 6.80-fold (1.47-31.49) for “borderline”
“rAAA” (P  .014) compared with “suitable” rAAA. The selection affect
was sustained for 5 years of follow-up.
Comment: The authors’ overall results for repair of rAAA with open
surgery are superior to most other results reported. In the authors’ center,
endovascular repair of rAAA is therefore not likely to lead to a dramatic
increase in survival of the rAAA patient. The authors point out that other,
often forgotten measures, such as rapid diagnosis, rapid transfer, low-
volume resuscitation, systematic imaging, dedicated cardiovascular anesthe-
sia, and a high volume of rAAA repairs are all factors that contribute to
survival of the rAAA patient. At this point the available literature, as an
aggregate, would suggest that endovascular and open repair of rAAA can
both be effective procedures in the hands of appropriately trained and
experienced surgeons.
Long-Term Outcome of Aortic Dissection With Patent False Lumen:
Predictive Role of Entry Tear Size and Location
Evangelista A, Salas A, Ribera A, et al. Circulation 2012;125:3133-41.
Conclusion: A patent false lumen after aortic dissection has a high risk
of complications. Marfan syndrome, aortic diameter, and a large entry tear
located in the proximal part of the dissection identify high-risk subgroups of
patients who may benefit from earlier and more aggressive therapy.
Summary: Persistence of a patent false lumen in the descending aorta
after type A or type B aortic dissection is associated with poor prognosis
(Bernard Y et al, Am J Cardiol 2001;87:1378-82). The expectation was that
thoracic endovascular aortic repair for earlymanagement of aortic dissection,
by occluding the intimal tear and promoting false lumen thrombosis, would
result in better outcomes for the aortic dissection patient. To date however,
no study has demonstrated that elective endovascular treatment in the early
course of aortic dissection reduces mortality. In fact, the INSTEAD trial
failed to show a benefit in 2-year survival and adverse event rates after early
treatment of type B aortic dissection (Nienaber AN et al, Circulation
2009;120:2519-28). The “logic” of treating aortic dissection in the sub-
acute phase with endografts, coupled with the results of the INSTEAD trial,
has led investigators to try to identify clinical and imaging predictors of
prognosis and therefore, by inference, which patients may benefit from early
intervention after thoracic aortic dissection. The authors sought to define
such clinical and imaging variables in the subacute phase of aortic dissection.
They analyzed 184 consecutive patients: 108 surgically treated type A and
76 medically treated type B dissections who were discharged after acute
aortic dissection with a patent false lumen. Before discharge, transesopha-
geal echocardiograms were preformed. Computed tomography angiogra-
phy was performed at 3 months and yearly thereafter. Median follow-up was
6.42 years (quartile 1 to 3: 3.31 to 10.49). During follow-up, 49 patients
died (22 type A, 27 type B), of which 31 deaths were sudden deaths. Late
surgical or endovascular treatment was indicated in 10 type A and 25 type B
patients. Survival free from sudden death and surgical/endovascular treat-
ment was 0.90, 0.81, and 0.46 (95% confidence interval, 0.36-0.55) at 3, 5,
and 10 years, respectively. Multivariate analysis identified maximum baseline
descending aortic diameter (hazard ratio [HR], 1.32 [1.10-1.59]; P 
.003), proximal location (HR, 1.84 [1.06-3.19]; P  .03), and entry tear
size (HR, 1.13 [1.08-1.2]; P  .001) as predictors of dissection-related
adverse events. Mortality was predicated by maximum descending aortic
diameter (HR, 1.36 [1.08-1.70]; P  .008), entry tear size (HR, 1.1
[1.04-1.16]; P .001), and Marfan syndrome (HR, 3.66 [1.65-8.13]; P
.001).
Comment: This study focuses on clinical and imaging predictors
potentially identified early on after type A or type B dissection that may affect
late mortality or need for further intervention. Given the results of the
1472
INSTEAD trial and the known adverse affects of a patent false lumen after
aortic dissection, studies such as this focusing on variables that can be
identified after dissection as possible indicators for early endovascular ther-
apy are clearly needed. Although patients with Marfan syndrome are not
thought to be optimal candidates for endovascular treatments, non-Marfan
patients with large proximal aortic tears and large aortas would seem to be
two subgroups that would benefit from further study for “prophylactic”
endovascular thoracic aortic repair after acute thoracic aortic resection.
Meta-Analysis of Individual Patient Data to Examine Factors Affecting
Growth and Rupture of Small Abdominal Aortic Aneurysms
Sweeting MJ, Thompson SG, Brown LC, et al; RESCAN collaborators. Br
J Surg 2012;99:655-65.
Conclusion:Risk factors differ for growth and rupture of small abdom-
inal aortic aneurysms (AAAs). In addition to aneurysm diameter, diabetes
and smoking may need to be considered in developing schedules for surveil-
lance of small AAAs. No single drug for cardiovascular risk reduction has a
pronounced affect on rupture or growth of small AAAs.
Summary: It is now well established that screening for AAAs can
reduce aneurysm-related mortality. Individual aneurysm and patient-specific
factors affecting small AAA growth rate and rupture potential are not well
established. Rupture of a small AAA is infrequent, and because most studies
are small, there are little convincing data about factors that might affect risk
of rupture of a small AAA. In addition, studies of growth rates of small AAAs
have made minimal attempts to adjust for the multiplicity of potential risk
factors in patients with AAA or to identify modifiers of aneurysm growth rate
such as diabetes or smoking (Bergqvist D, Eur J Vasc Endovasc Surg
2011;41:663-1; and Powel JT et al, Br J Surg 2011;98:609-19; and Brady
AR et al, Circulation 2004;110:16-21). In this report the authors used
individual patient data from 15,000 people under follow-up for a small
AAA to identify whether any of the common cardiovascular risk factors or
classes of drugs used by patients with aneurysms influence growth and
rupture rates of small AAAs. The authors requested individual patient data
from corresponding authors of 25 studies that included 100 patients with
a small AAA. Eighteen studies provided data to the RESCAN collaborators
and 15,475 people were entered into the database. The effects of covariables
(patient demographics, medical, and drug history) on AAA growth rate were
summarized in an individual patient meta-analysis. Analysis used longitudi-
nal random-affects modeling and survival analysis adjusted for aneurysm
diameter. The mean AAA growth rate was 2.21 mm/y. AAA growth was
independent of age and sex. The growth rate in smokers was increased by
0.35 mm/y, and the growth rate in patients with diabetes was decreased by
0.51 mm/y. Cardioprotective medications, mean arterial pressure, or use of
antihypertensive medications had no significant effects on AAA growth.
Calendar year of enrollment in the study was not associated with growth
rate. Rupture rates were almost fourfold higher in woman than men (P 
.001). Rupture rates were double in current smokers (P  .001) and
increased with higher blood pressure (P  .001).
Comment: The article points out that variables affecting growth of a
small AAA differ from variables affecting rupture of a small AAA. The
implications are that patients with diabetes and small AAAs perhaps can be
followed up less frequently than those without diabetes and that patients
who continue to smoke perhaps should be followed up more frequently.
With respect to rupture, the data suggest the potential of a lower threshold
for surgical intervention in women and possibly also in smokers who are
unable to successfully abstain from tobacco use. Use of drugs to modify
cardiovascular risk factors does not appear to have a major effect on growth
or rupture of small AAAs.
Midline AbdominalWall Incisional Hernia After Aortic Reconstructive
Surgery: A Prospective Study
Gruppo N, Mazzali F, Lorenzetti R, et al. Surgery 2012;151:882-8.
Conclusion: Patients with abdominal aortic aneurysm (AAA) and
aortic occlusive disease (AOD) have a similar incidence ofmidline abdominal
incisional hernia (MAIH) after midline transperitoneal aortic reconstruc-
tion. A suture length-to-wound length ratio of 4:1 is associated with
midline abdominal hernia after transperitoneal repair of AAA and AOD.
Summary:MAIH is reported in up to 11% of patients after laparotomy
and in up to 23% patients who develop midline wound infections (Hodgson
NCF et al, Ann Surg 2000;231:436-42; and Cassar K et al, Br J Surg
2002;89:534-45). Because 35% of MAIHs develop 5 years postopera-
tively, short-term observations underestimate the prevalence of MAIH after
laparotomy (Mudge M, Hughes LE, Br J Surg 1985;72:70-1). There is
controversy whether MAIH occurs more frequently after AAA repair than
after revascularization for AOD or other conditions (Adye B, Luna G, Am J
Surg 1998;175:400-2; and Johnson B et al, Cardiovasc Surg 1995:36:487-
90). Some have suggested that a possible higher incidence of MAIH in AAA
patients may reflect a genetic predisposition for a structural connective tissue
disorder in the aortic wall and the aponeurotic sheet of the abdominal
muscles. However, no specific pathogenesis has been described linking these
two disorders. In this report, the authors have evaluated the development of
MAIH after elective open repair of AAA vs revascularization for AOD.
Patients were operated on through a midline abdominal incision during a
10-year period. Data were recorded prospectively. Those patients who had a
pervious midline laparotomy or who had an MAIH after a previous laparot-
omy were excluded. Follow-up for MAIH was every 6 months for 2 years,
then yearly. Assessment for MAIH was by physical examination. When
MAIH was suspected, abdominal wall magnetic resonance imaging or
computed tomography imaging was preformed. There were 1,065 patients
who underwent aortic reconstructive surgery (412 with AAA and 653 with
AOD). Mean follow-up was 6.4  3.8 years (range, 0.5-12.7 years).
Vascular reconstruction was performed by the same vascular surgeon. Lap-
arotomy wounds were closed by three different surgeons. Closure was a
continuous running absorbable monofilament suture in a single layer with
mass closure technique. Lengths of the wound and the lengths of the suture
were measured, and a ratio of suture length/wound length was determined.
Wounds were closed with a suture length/wound length ratio of at least 4:1
in 58% of AAA patients and in 66% of AOD patients (P  .01). There were
124 (11.6%) MAIHs, with an incidence of 12.4% (51 of 412) in the AAA
group and 11.2% (73 of 653) in the AOD group (P  .062). Three wound
infections (0.4%) occurred, all in AOD patients, but none resulted in an
MAIH. Multivariate analysis showed a suture length/wound length ratio of
4:1 was the only independent predictor of MAIH in AAA ( P .004) and
AOD patients (P  .001). More than 60% of MAIHs developed between
years 1 and 2 after operation. The very large majority of the remainder was
evenly distributed between years 3 and 5.
Comment:The report’s primary finding is that the incidence ofMAIH
after aortic repair is similar for those undergoing repair for aneurysm as for
occlusive disease. This is different from the popular perception that midline
hernia is more common after AAA repair than after aortic surgery for AOD.
Possible explanations include the small number of AAA patients in many
previous investigations, the inclusion of emergency and elective AAA pro-
cedures, and inclusion in previous studies of patients with prior laparotomy
or wound infections. MAIH after midline laparotomy for aortic reconstruc-
tion therefore is perhaps best considered a multifactorial problem. When all
else is equal, rates of MAIH may not be all that different between patients
with AAA and those with AOD. In addition there seems to be no downside
of recommending a suture length/wound length ratio of at least 4:1 for
closure of midline laparotomy wounds.
Multicenter Experience on Eversion Versus Conventional Carotid
Endarterectomy in Symptomatic Carotid Artery Stenosis: Observa-
tions from the Stent-Protected Angioplasty versus Carotid Endarter-
ectomy (SPACE-1) Trial
Demirel S, Attigah N, Bruijnen H, et al; and the Space Investigators. Stroke
2012;43:1865-71.
Conclusion: Patients with cervical carotid artery stenosis undergoing
conventional carotid endarterectomy (C-CEA) have better periprocedural
outcomes than those undergoing eversionCEA (E-CEA).However, E-CEA
may be more efficacious for long-term prevention of ipsilateral stroke.
Summary: There are two basic techniques for CEA: C-CEA is per-
formed through a longitudinal arteriotomy and is generally closed with a
patch, and E-CEA is performed with an oblique transection of the internal
carotid artery off the common carotid artery with reimplantation of the
endarterectomized internal carotid artery onto the common carotid artery.
A Cochrane review in 2009 concluded that there was no evidence that one
technique was superior to the other with respect to periprocedural stroke,
death, or restenosis (Cao P et al, Cochrane Database Syst Rev 2002;1:
CD001921). In this report, the authors present a post hoc retrospective
analysis of the surgical arm of the Stent Protected Angioplasty versus Carotid
Endarterectomy trial (SPACE-1). All patients in the SPACE-1 trial were
symptomatic, and choice of CEA technique in the surgical arm was based on
surgeon preference. There were 601 eligible patients randomized into the
surgical arm of the SPACE-1 trial. After excluding patients who withdrew
consent before treatment, who did not undergo per-protocol treatment,
who experienced primary outcome before treatment, or who had CEA
without patch closure or prosthetic bypass graft interposition, there were
516 patients suitable for analysis. Of these, 310 (60.1%) underwent C-CEA
and 206 (39.9%) underwent E-CEA. The primary end point was ipsilateral
stroke or death 30 days after surgery. Secondary end points included
perioperative adverse events and the 2-year risk of restenosis, stroke, and
death. There were no restrictions with respect to type of anesthesia, neuro-
logic monitoring, heparin dose, type of patch to close the arteriotomy, or
indications for shunting. The C-CEA and E-CEA groups were similar in
demographics and baseline clinical variables. Shunt frequency was higher in
the C-CEA group (65% vs.17%; P .0001). Ipsilateral stroke or death30
days were significantly greater with E-CEA than C-CEA (9% vs 3%; P 
.005). There were no statistically significant differences in perioperative
secondary outcome events between the two groups with the exception of a
higher risk of intraoperative ipsilateral stroke in the E-CEA group (4% vs
0.3%; P  .0035). The 2-year risk of ipsilateral stroke after 30 days was
higher in the C-CEA group than in the E-CEA group (2.9% vs 0%; P 
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